RNA interference targeting Fas protects mice from fulminant hepatitis (original) (raw)

• Hannon, G.J. RNA interference. Nature 418, 244–251 (2002).
  Article CAS Google Scholar
• Rust, C. & Gores, G.J. Apoptosis and liver disease. Am. J. Med. 108, 567–574 (2000).
  Article CAS Google Scholar
• Elbashir, S.M. et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498 (2001).
  Article CAS Google Scholar
• Caplen, N.J., Parrish, S., Imani, F., Fire, A. & Morgan, R.A. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 98, 9742–9747 (2001).
  Article CAS Google Scholar
• McCaffrey, A.P. et al. RNA interference in adult mice. Nature 418, 38–39 (2002).
  Article CAS Google Scholar
• Lewis, D.L., Hagstrom, J.E., Loomis, A.G., Wolff, J.A. & Herweijer, H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat. Genet. 32, 107–108 (2002).
  Article CAS Google Scholar
• Xia, H., Mao, Q., Paulson, H.L. & Davidson, B.L. siRNA-mediated gene silencing in vitro and in vivo. Nat. Biotechnol. 20, 1006–1010 (2002).
  Article CAS Google Scholar
• Kondo, T., Suda, T., Fukuyama, H., Adachi, M. & Nagata, S. Essential roles of the Fas ligand in the development of hepatitis. Nat. Med. 3, 409–413 (1997).
  Article CAS Google Scholar
• Siegel, R.M. & Fleisher, T.A. The role of Fas and related death receptors in autoimmune and other disease states. J. Allergy Clin. Immunol. 103, 729–738 (1999).
  Article CAS Google Scholar
• Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806–809 (1993).
  Article CAS Google Scholar
• Li, X.K. et al. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers. Transplantation 71, 503–508 (2001).
  Article CAS Google Scholar
• Canbay, A. et al. Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis. Gastroenterology 123, 1323–1330 (2002).
  Article CAS Google Scholar
• Zhang, G., Budker, V. & Wolff, J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735–1737 (1999).
  Article CAS Google Scholar
• Zhang, H. et al. Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis. Nat. Biotechnol. 18, 862–867 (2000).
  Article CAS Google Scholar
• Bertrand, J. et al. Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem. Biophys. Res. Commun. 296, 1000–1004 (2002).
  Article CAS Google Scholar
• Schwarz, D.S., Hutvagner, G., Haley, B. & Zamore, P.D. Evidence that siRNAs function as guides, not primers, in the Drosophila and human RNAi pathways. Mol. Cell 10, 537–548 (2002).
  Article CAS Google Scholar
• Ketting, R.F. et al. Dicer functions in RNA interference and in synthesis of small RNA involved in developmental timing in C. elegans. Genes Dev. 15, 2654–2659 (2001).
  Article CAS Google Scholar
• Lipardi, C., Wei, Q. & Paterson, B.M. RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs. Cell 107, 297–307 (2001).
  Article CAS Google Scholar
• Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969–976 (1994).
  Article CAS Google Scholar
• Ryo, K. et al. Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failure. Am. J. Gastroenterol. 95, 2047–2055. (2000).
  Article CAS Google Scholar
• Faouzi, S. et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-κB-independent, caspase-3-dependent pathway. J. Biol. Chem. 276, 49077–49082 (2001).
  Article CAS Google Scholar
• Seino, K. et al. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113, 1315–1322 (1997).
  Article CAS Google Scholar
• Takeda, K. et al. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97, 5498–5503 (2000).
  Article CAS Google Scholar
• Miyazawa, Y., Tsutsui, H., Mizuhara, H., Fujiwara, H. & Kaneda, K. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice. Hepatology 27, 497–506 (1998).
  Article CAS Google Scholar
• Galle, P.R. et al. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223–1230 (1995).
  Article CAS Google Scholar
• Takahashi, S. & Lee, M.J. Collagen metabolism in fibrotic liver. Effects of concanavalin A and aggregated myeloma immunoglobin G. Biochem. J. 241, 49–54 (1987).
  Article CAS Google Scholar
• Badawy, A.A. et al. Evaluation of colchicine with or without praziquantel therapy in the control of hepatic fibrosis in murine schistosomiasis. Pharmacol. Res. 33, 319–325 (1996).
  Article CAS Google Scholar
• Dhiman, R.K., Seth, A.K., Jain, S., Chawla, Y.K. & Dilawari, J.B. Prognostic evaluation of early indicators in fulminant hepatic failure by multivariate analysis. Dig. Dis. Sci. 43, 1311–1316 (1998).
  Article CAS Google Scholar
• Klauning, J.E. et al. Mouse liver cell culture. 1. Hepatocyte isolation. In Vitro 17, 913–925 (1981).
• Kimura, K. et al. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A. Int. Immunol. 11, 1491–1500 (1999).
  Article CAS Google Scholar